Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure

MASAHIRO KAMO, RINTARO SOGAWA and CHISATO SHIMANOE
In Vivo July 2024, 38 (4) 1841-1846; DOI: https://doi.org/10.21873/invivo.13637
MASAHIRO KAMO
Department of Pharmacy, Saga University Hospital, Saga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RINTARO SOGAWA
Department of Pharmacy, Saga University Hospital, Saga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sogawari{at}cc.saga-u.ac.jp
CHISATO SHIMANOE
Department of Pharmacy, Saga University Hospital, Saga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 4 1841-1846
DOI 
https://doi.org/10.21873/invivo.13637
PMID 
38936945

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received February 15, 2024
  • Revision received March 13, 2024
  • Accepted March 14, 2024
  • Published online June 27, 2024.

Copyright & License 
Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. MASAHIRO KAMO,
  2. RINTARO SOGAWA⇑ and
  3. CHISATO SHIMANOE
  1. Department of Pharmacy, Saga University Hospital, Saga, Japan
  1. Correspondence to: Rintaro Sogawa, Ph.D., Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga 849-8501, Japan. Fax: +81 952342036, Tel: +81 952316511, e-mail: sogawari{at}cc.saga-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo: 38 (4)
In Vivo
Vol. 38, Issue 4
July-August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure
MASAHIRO KAMO, RINTARO SOGAWA, CHISATO SHIMANOE
In Vivo Jul 2024, 38 (4) 1841-1846; DOI: 10.21873/invivo.13637

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure
MASAHIRO KAMO, RINTARO SOGAWA, CHISATO SHIMANOE
In Vivo Jul 2024, 38 (4) 1841-1846; DOI: 10.21873/invivo.13637
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Signal Detection Analysis of Hypnotic-induced Respiratory Depression
  • Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan
  • Google Scholar

More in this TOC Section

  • Evaluation of Cement Leakage and Complications After Cement-augmented Pedicle Screw Fixation: A Retrospective Case Series
  • Comparison of Early Response to Selumetinib Therapy in Adolescents and Children With NF1-related Plexiform Neurofibromas
  • Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS
Show more Clinical Studies

Keywords

  • Coronavirus Disease 2019
  • Acute kidney injury
  • pharmacovigilance
In Vivo

© 2026 In Vivo

Powered by HighWire